AVNS - Avanos Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
48.46
+1.15 (+2.43%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close 47.31
Open 47.56
Bid 0.00 x 900
Ask 0.00 x 1000
Day's Range 47.32 - 48.51
52 Week Range 38.00 - 72.96
Volume 188,854
Avg. Volume 397,603
Market Cap 2.298B
Beta (3Y Monthly) 1.29
PE Ratio (TTM) 24.71
EPS (TTM) 1.96
Earnings Date Feb 26, 2019
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 55.43
Trade prices are not sourced from all markets
  • Avanos Medical, Inc. (NYSE:AVNS): Financial Strength Analysis
    Simply Wall St. 5 days ago

    Avanos Medical, Inc. (NYSE:AVNS): Financial Strength Analysis

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Small-caps and large-caps are wildly popular amongRead More...

  • PR Newswire 6 days ago

    Avanos Medical, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2018 Financial Results

    ALPHARETTA, Ga., Feb. 12, 2019 /PRNewswire/ -- Avanos Medical, Inc. (AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-year 2018 and its 2019 outlook on Tuesday, Feb. 26 at 9 a.m. ET. The conference call will be hosted by Joe Woody, chief executive officer, and Steve Voskuil, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States.

  • Markit 10 days ago

    See what the IHS Markit Score report has to say about Avanos Medical Inc.

    Avanos Medical Inc NYSE:AVNSView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for AVNS with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding AVNS totaled $425 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • PR Newswire 2 months ago

    Avanos Medical, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference

    ALPHARETTA, Ga. , Jan. 3, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the 37 th Annual J.P. Morgan Healthcare Conference ...

  • Hedge Funds Are Betting On Avanos Medical, Inc. (AVNS)
    Insider Monkey 2 months ago

    Hedge Funds Are Betting On Avanos Medical, Inc. (AVNS)

    Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap […]

  • PR Newswire 2 months ago

    Avanos Medical, Inc. Appoints David Ball as Senior Vice President, Global Supply Chain & Procurement

    ALPHARETTA, Ga. , Dec. 17, 2018 /PRNewswire/ -- Avanos Medical, Inc. today announced that David Ball has been appointed senior vice president, global supply chain & procurement. In this role, Ball will ...

  • PR Newswire 2 months ago

    Avanos Among Winners of FDA's Opioid Innovation Challenge

    ALPHARETTA, Ga., Dec. 10, 2018 /PRNewswire/ -- Avanos Medical, Inc. (AVNS) is pleased to announce it has been selected as one of eight winners of the FDA's Opioid Addiction Innovation Challenge. The FDA launched the challenge in May 2018 to spur the development of medical devices and solutions to help combat the growing epidemic of opioid misuse and abuse. Avanos was selected as one of eight winners among more than 250 submissions from medical device companies and/or developers.

  • GuruFocus.com 3 months ago

    Avanos Medical Inc (AVNS) CEO Joseph Fralin Woody Bought $151,725 of Shares

    CEO of Avanos Medical Inc (NYSE:AVNS) Joseph Fralin Woody bought 3,500 shares of AVNS on 11/28/2018 at an average price of $43.35 a share.

  • Avanos Medical Presents New Preclinical Data Comparing the Outcomes of COOLIEF* Cooled Radiofrequency to Standard RF
    PR Newswire 3 months ago

    Avanos Medical Presents New Preclinical Data Comparing the Outcomes of COOLIEF* Cooled Radiofrequency to Standard RF

    Data from Avanos Medical offers guidance to understanding long-term pain relief seen in cooled radiofrequency versus standard techniques. ALPHARETTA, Ga. , Nov. 16, 2018 /PRNewswire/ -- Avanos Medical, ...

  • Avanos Medical (AVNS) Q3 Earnings Surpass Estimates
    Zacks 3 months ago

    Avanos Medical (AVNS) Q3 Earnings Surpass Estimates

    Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.59% and -0.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire 3 months ago

    Avanos Medical, Inc. Announces Third Quarter 2018 Results, Affirms Full-Year Adjusted Diluted Earnings Per Share Guidance

    ALPHARETTA, Ga. , Nov. 6, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2018 results and affirmed its full-year 2018 adjusted diluted earnings per share outlook of ...

  • PR Newswire 3 months ago

    Avanos Medical, Inc. to Present at Stifel 2018 Healthcare Conference

    ALPHARETTA, Ga. , Nov. 5, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the Stifel 2018 Healthcare Conference at The Lotte ...

  • PR Newswire 4 months ago

    Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2018 Financial Results

    ALPHARETTA, Ga. , Oct. 23, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2018 on Tuesday, ...

  • PR Newswire 5 months ago

    Avanos Medical, Inc. to Present at Morgan Stanley Global Healthcare Conference

    ALPHARETTA, Ga. , Sept. 6, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Steve Voskuil , chief financial officer, will present at the Morgan Stanley Global Healthcare Conference ...

  • Avanos Medical (AVNS) Jumps: Stock Rises 5.5%
    Zacks 6 months ago

    Avanos Medical (AVNS) Jumps: Stock Rises 5.5%

    Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

  • Are Avanos Medical Inc’s (NYSE:AVNS) Interest Costs Too High?
    Simply Wall St. 6 months ago

    Are Avanos Medical Inc’s (NYSE:AVNS) Interest Costs Too High?

    Stocks with market capitalization between $2B and $10B, such as Avanos Medical Inc (NYSE:AVNS) with a size of US$2.69b, do not attract as much attention from the investing community asRead More...